Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1680985, 7 pages
https://doi.org/10.1155/2017/1680985
Clinical Study

Beneficial Effects of 6-Month Supplementation with Omega-3 Acids on Selected Inflammatory Markers in Patients with Chronic Kidney Disease Stages 1–3

1Division of Community Nursing, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Łukasiewicza 1 Street, 85-821 Bydgoszcz, Poland
2Department of Nephrology, Hypertension and Internal Diseases, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, M. Skłodowskiej-Curie 9 Street, 85-094 Bydgoszcz, Poland
3Faculty of Biology and Environmental Protection, Nicolaus Copernicus University in Toruń, Lwowska 1 Street, 87-100 Toruń, Poland
4Department of Allergology, Clinical Immunology and Internal Diseases, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland
5Department of Laboratory Medicine, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, M. Skłodowskiej-Curie 9 Street, 85-094 Bydgoszcz, Poland

Correspondence should be addressed to Agnieszka Pluta; lp.teno.atzcop@atulpakzseinga

Received 23 August 2017; Accepted 15 October 2017; Published 19 November 2017

Academic Editor: Gang Liu

Copyright © 2017 Agnieszka Pluta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Locatelli, B. Canaud, K.-U. Eckardt, P. Stenvinkel, C. Wanner, and C. Zoccali, “Oxidative stress in end-stage renal disease: an emerging treat to patient outcome,” Nephrology Dialysis Transplantation , vol. 18, no. 7, pp. 1272–1280, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Amdur, H. I. Feldman, J. Gupta et al., “Inflammation and Progression of CKD: The CRIC Study,” Clinical Journal of the American Society of Nephrology, vol. 11, no. 9, pp. 1546–1556, 2016. View at Publisher · View at Google Scholar
  3. F. C. Amparo, M. A. Kamimura, M. Z. Molnar et al., “Diagnostic validation and prognostic significance of the Malnutrition-Inflammation Score in nondialyzed chronic kidney disease patients,” Nephrology Dialysis Transplantation , vol. 30, no. 5, pp. 821–828, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. N. D. Vaziri, “Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease,” Journal of Renal Nutrition, vol. 20, no. 5, supplement, pp. S35–S43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Swaminathan and S. V. Shah, “Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease,” Kidney International, vol. 80, no. 5, pp. 453–463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Pasceri, J. T. Willerson, and E. T. H. Yeh, “Direct proinflammatory effect of C-reactive protein on human endothelial cells,” Circulation, vol. 102, no. 18, pp. 2165–2168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. C. D. A. Stehouwer, “Endothelial dysfunction in diabetic nephropathy: State of the art and potential significance for non-diabetic renal disease,” Nephrology Dialysis Transplantation , vol. 19, no. 4, pp. 778–781, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Pecoits-Filho, P. Bárány, B. Lindholm, O. Heimbürger, and P. Stenvinkel, “Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment,” Nephrology Dialysis Transplantation , vol. 17, no. 9, pp. 1684–1688, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H. R. Vianna, C. M. B. M. Soares, K. D. Silveira et al., “Cytokines in chronic kidney disease: Potential link of MCP-1 and dyslipidemia in glomerular diseases,” Pediatric Nephrology, vol. 28, no. 3, pp. 463–469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Viedt and S. R. Orth, “Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?” Nephrology Dialysis Transplantation , vol. 17, no. 12, pp. 2043–2047, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Kishimoto, “Interleukin-6: discovery of pleiotropic cytokine,” Arthritis Research & Therapy, vol. 8, supplement 2, article S2, 2006. View at Google Scholar
  12. C. Viedt, J. Vogel, T. Athanasiou et al., “Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-κB and activator protein-1,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 6, pp. 914–920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Sicińska, E. Pytel, J. Kurowska, and M. Koter-Michalak, “Supplementation with omega fatty acids in various diseases,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 69, pp. 838–852, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. R. G. Fassett, G. C. Gobe, J. M. Peake, and J. S. Coombes, “Omega-3 polyunsaturated fatty acids in the treatment of kidney disease,” American Journal of Kidney Diseases, vol. 56, no. 4, pp. 728–742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Lee and W. S. An, “Cardioprotective effects of -3 PUFAs in chronic kidney disease,” BioMed Research International, vol. 2013, Article ID 712949, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Deike, R. G. Bowden, J. J. Moreillon et al., “The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients,” Journal of Renal Nutrition, vol. 22, no. 6, pp. 572–577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Bondia-Pons, A. I. Castellote, and M. C. López-Sabater, “Comparison of conventional and fast gas chromatography in human plasma fatty acid determination,” Journal of Chromatography B, vol. 809, no. 2, pp. 339–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gluba-Brzózka, M. Michalska-Kasiczak, B. Franczyk et al., “Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study,” Lipids in Health and Disease, vol. 15, no. 1, article 32, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Pluta, P. Strózecki, M. Krintus, G. Odrowąz-Sypniewska, and J. Manitius, “Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3,” Renal Failure, vol. 37, no. 7, pp. 1105–1110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Huang, B. Lindholm, P. Stenvinkel, and J. J. Carrero, “Dietary fat modification in patients with chronic kidney disease: N-3 fatty acids and beyond,” Journal of Nephrology, vol. 26, no. 6, pp. 960–974, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. M. Aukema, “Lipids in chronic kidney disease: Alterations and interventions,” Lipid Technology, vol. 25, no. 9, pp. 207–209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Lauretani, M. Maggio, F. Pizzarelli et al., “Omega-3 and renal function in older adults,” Current Pharmaceutical Design, vol. 15, no. 36, pp. 4149–4156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Castellani, R. Paniccia, C. Di Serio et al., “Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure,” Journal of the American College of Cardiology, vol. 42, no. 1, pp. 133–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Z. Nowak, “Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 64, pp. 115–132, 2010. View at Google Scholar · View at Scopus
  26. A. M. Hung, C. Booker, C. D. Ellis et al., “Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients,” Nephrology Dialysis Transplantation , vol. 30, no. 2, pp. 266–274, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. W. S. An, H. J. Kim, K.-H. Cho, and N. D. Vaziri, “Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney,” American Journal of Physiology-Renal Physiology, vol. 297, no. 4, pp. F895–F903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Tayyebi-Khosroshahi, J. Houshyar, R. Dehgan-Hesari et al., “Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients,” Saudi Journal of Kidney Diseases and Transplantation, vol. 23, no. 3, pp. 500–506, 2012. View at Google Scholar · View at Scopus
  29. S. Giunti, G. H. Tesch, S. Pinach et al., “Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells,” Diabetologia, vol. 51, no. 1, pp. 198–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Haller, A. Bertram, F. Nadrowitz, and J. Menne, “Monocyte chemoattractant protein-1 and the kidney,” Current Opinion in Nephrology and Hypertension, vol. 25, no. 1, pp. 42–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Deshmane, S. Kremlev, S. Amini et al., “Monocyte Chemoattractant Protein-1 (MCP-1): an overview,” Journal of Interferon & Cytokine Research, vol. 29, no. 6, pp. 313–326, 2009. View at Google Scholar
  32. A. E. Naini, R. E. Asiabi, N. Keivandarian, and F. Moeinzadeh, “Effect of omega-3 supplementation on inflammatory parameters in patients on chronic ambulatory peritoneal dialysis,” Advanced Biomedical Research, vol. 10, no. 4, pp. 167–172, 2015. View at Publisher · View at Google Scholar
  33. T. Madsen, E. B. Schmidt, and J. H. Christensen, “The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure,” Journal of Renal Nutrition, vol. 17, no. 4, pp. 258–263, 2007. View at Publisher · View at Google Scholar